MT694613
Miniopterus fuliginosus isolate N20110 D-loop, partial sequence; mitochondrial.
294
DNA
Miniopterus fuliginosus
N20110
yx29b01.s1 Soares melanocyte 2NbHM Homo sapiens cDNA clone IMAGE:263113 3' similar to gb:M64241 QM PROTEIN (HUMAN);contains Alu repetitive element, mRNA sequence.
251
mRNA
Homo sapiens
DJ149490
JP 2007228956-A/20108: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
HV876651
JP 2010507387-A/20062: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LZ207187
JP 2017148060-A/20110: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY.
18
RNA
synthetic construct
DM721255
JP 2016500250-A/20110: ENGINEERED SECRETED PROTEINS AND METHODS.
659
PRT
Escherichia coli
DL901854
JP 2014205669-A/20110: Method of constructing and screening libraries of peptide structures.
22
PRT
synthetic construct
DL610712
JP 2011092200-A/20110: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
LV565932
JP 2017029159-A/20110: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA390833
JP 2021533803-A/19916: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
DM756804
JP 2014079248-A/20110: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
OG656496
JP 2021500321-A/20110: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
HZ524891
JP 2016501039-A/20110: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MD752352
JP 2019507579-A/20110: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
DD546713
JP 2004508801-A/20110: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
MC903848
JP 2018536623-A/20110: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
37
PRT
synthetic construct
MC772220
JP 2018525446-A/20110: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
31
PRT
synthetic construct
MC161954
JP 2019500349-A/20110: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
HW567175
JP 2014509511-A/20110: OLIGONUCLEOTIDE MODULATORS OF THE TOLL-LIKE RECEPTOR PATHWAY.
18
RNA
synthetic construct
HW855334
JP 2015051004-A/20062: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA524594
JP 2022502046-A/7376: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DJ523910
JP 2010517930-A/20110: Method of constructing and screening libraries of peptide structures.
22
PRT
synthetic construct
MB762271
JP 2018535655-A/26168: ASGR INHIBITORS.
9
PRT
synthetic construct
MD266243
JP 2020517247-A/20110: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DL029124
JP 2005512499-A/20110: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
1079
DNA
synthetic construct
PA335758
JP 2021522188-A/20110: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
MB809368
JP 2019502674-A/20110: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
40
PRT
synthetic construct
DM794568
JP 2014068652-A/20110: NEISSERIAL ANTIGENIC PEPTIDES.
5
PRT
Neisseria
OG749629
JP 2021120380-A/20110: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
LX117726
JP 2017506877-A/20108: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct